HSBC Call 300 AMGN 15.01.2027/ DE000HT1P411 /
06/01/2025 21:35:36 | Var.-0.250 | Denaro21:59:26 | Lettera21:59:26 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.850EUR | -8.06% | 2.880 Quantità in denaro: 5,000 |
2.900 Quantità in lettera: 5,000 |
Amgen Inc | 300.00 USD | 15/01/2027 | Call |
GlobeNewswire
29/08/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
28/08/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
15/08/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
12/08/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08/08/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/08/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
05/08/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
01/08/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024